Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru

被引:51
作者
Campos, PE
Suarez, PG
Sanchez, J
Zavala, D
Arevalo, J
Ticona, E
Nolan, CM
Hooton, TM
Holmes, KK
机构
[1] Univ Washington, Ctr AIDS & STD, Seattle, WA 98104 USA
[2] Cayetano Heredia Univ, Lima, Peru
[3] Peruvian Minist Hlth, Lima, Peru
[4] Asociac Civil Impacta Salud & Educ, IMPACTA, Lima, Peru
[5] Publ Hlth Seattle King Cty, Seattle, WA USA
关键词
D O I
10.3201/eid0912.020731
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
During 1999 to 2000, we identified HIV-infected persons with new episodes of tuberculosis (TB) at 10 hospitals in Lima, Peru, and a random sample of other Lima residents with TB. Multidrug-resistant (MDR)-TB was documented in 35 (43%) of 81 HIV-positive patients and 38 (3.9%) of 965 patients who were HIV-negative or of unknown HIV status (p < 0.001). HIV-positive patients with MDR-TB were concentrated at three hospitals that treat the greatest numbers of HIV-infected persons with TB. Of patients with TB, those with HIV infection differed from those without known HIV infection in having more frequent prior exposure to clinical services and more frequent previous TB therapy or prophylaxis. However, MDR-TB in HIV-infected patients was not associated with previous TB therapy or prophylaxis. MDR-TB is an ongoing problem in HIV-infected persons receiving care in public hospitals in Lima and Callao; they represent sentinel cases for a potentially larger epidemic of nosocomial MDR-TB.
引用
收藏
页码:1571 / 1578
页数:8
相关论文
共 34 条
[1]  
Angarano G, 1998, INT J TUBERC LUNG D, V2, P303
[2]  
[Anonymous], 1994, Morbidity and Mortality Weekly Report, V43, P1
[3]   HOSPITAL OUTBREAK OF MULTIDRUG-RESISTANT MYCOBACTERIUM-TUBERCULOSIS INFECTIONS - FACTORS IN TRANSMISSION TO STAFF AND HIV-INFECTED PATIENTS [J].
BECKSAGUE, C ;
DOOLEY, SW ;
HUTTON, MD ;
OTTEN, J ;
BREEDEN, A ;
CRAWFORD, JT ;
PITCHENIK, AE ;
WOODLEY, C ;
CAUTHEN, G ;
JARVIS, WR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (10) :1280-1286
[4]   The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USA [J].
Bradford, WZ ;
Martin, JN ;
Reingold, AL ;
Schecter, GF ;
Hopewell, PC ;
Small, PM .
LANCET, 1996, 348 (9032) :928-931
[5]  
CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21
[6]  
*CDCP, 2002, MMWR-MORBID MORTAL W, V51, P414
[7]   Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection [J].
Chaisson, RE ;
Clermont, HC ;
Holt, EA ;
Cantave, M ;
Johnson, MP ;
Atkinson, J ;
Davis, H ;
Boulos, R ;
Quinn, TC ;
Halsey, NA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (04) :1034-1038
[8]   AN OUTBREAK OF TUBERCULOSIS WITH ACCELERATED PROGRESSION AMONG PERSONS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS - AN ANALYSIS USING RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS [J].
DALEY, CL ;
SMALL, PM ;
SCHECTER, GF ;
SCHOOLNIK, GK ;
MCADAM, RA ;
JACOBS, WR ;
HOPEWELL, PC .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (04) :231-235
[9]  
DeCock KM, 1997, GENITOURIN MED, V73, P322
[10]  
Dye C, 2000, RESURG EMERGING INFE, V1, P253